Add Yahoo as a preferred source to see more of our stories on Google. (Reuters) - Diversified healthcare company Abbott Laboratories on Friday agreed to buy Alere Inc at a lower price than it had ...
Alere, Inc. and its San Diego subsidiary, agreed to pay $38.75 million to resolve False Claims Act charges for billing the Medicare program for defective rapid point-of-care testing devices. Alere ...
, an Alere subsidiary specializing in analytics and clinical decision support (CDS) technology, today announced the launch of its Clinical Surveillance product for hospitals, which is an automated ...
Federal criminal investigators have opened a new front in a probe of diagnostic testing company Alere, according to a new report that comes as the firm continues trying to sell itself to in a ...
Shares of Alere (NYSE: ALR), a provider of diagnostic tests to the medical community for disease detection, plunged as much as 16% during Friday's trading session after releasing disappointing ...
North suburban-based Abbott Laboratories is making up with Alere after nearly a year of fighting, agreeing to buy the Massachusetts-based company for a lower price and ending its legal battles over ...
Alere's Apollo technology, a fully integrated health management solution connecting providers, payers and patients, combined with Business Process Management (BPM) technology from Pegasystems, will ...
Abbott Laboratories announced Wednesday that it has filed a complaint with a Delaware court to force a termination of its proposed $5.8 billion purchase of Alere, the market leader in ...
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. So what: Alere ...
Shares in Waltham, Mass.-based Alere rose after the company publically agreed to hand over documents disclosing its foreign operations and U.S. billing practices to Abbot Park, Ill.-based Abbott ...
Alere agreed to pay $33.2 million to resolve False Claims Act allegations that it knowingly sold defective point-of-care diagnostic testing devices. Here are five insights. 1. The U.S. Justice ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results